About this trial
The purpose of this study is to see if wearable sensor technology can be used to evaluate muscle activity and/or identify atypical muscle tone in infants up to 48 weeks postmenstrual age (8 weeks corrected age). These sensors are placed on the surface of the skin and record data about a child's body movements and muscle activity.
Eligibility criteria
Qualifiers
Hospitalized in the NICU
AND >38 weeks post-menstrual age
AND abnormal normal brain imaging OR Apgar score <7 at five minutes with umbilical cord pH (if obtained) <7.15
AND 2 or more warning signs for muscle tone or posture using the HNNE short form
Disqualifiers
Missing or incomplete limbs (such as from amputation or congenital limb defects).
Open wounds or skin breakdown on the limbs or torso.
Presence of known genetic syndrome or congenital anomalies requiring surgery or affecting function
Use of sedative medications (may include phenobarbital if level stable and therapeutic)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Shirley Ryan AbilityLab
Lead sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Collaborator
Northwestern University
Collaborator